Goldman Sachs Group Inc Altimmune, Inc. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,010,149 shares of ALT stock, worth $6.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,010,149
Previous 861,415 17.27%
Holding current value
$6.81 Million
Previous $8.77 Million 23.4%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$5.91 - $10.23 $879,017 - $1.52 Million
148,734 Added 17.27%
1,010,149 $6.72 Million
Q1 2024

May 15, 2024
BUY
$8.22 - $13.81 $2.77 Million - $4.66 Million
337,165 Added 64.31%
861,415 $8.77 Million
Q4 2023

Feb 13, 2024
BUY
$2.14 - $11.62 $859,781 - $4.67 Million
401,767 Added 328.02%
524,250 $5.9 Million
Q3 2023

May 14, 2024
SELL
$2.4 - $3.45 $964,240 - $1.39 Million
-401,767 Reduced 76.64%
122,483 $318,000
Q3 2023

Nov 14, 2023
SELL
$2.4 - $3.45 $121,653 - $174,877
-50,689 Reduced 29.27%
122,483 $318,000
Q2 2023

May 14, 2024
SELL
$3.45 - $5.97 $2.35 Million - $4.07 Million
-681,887 Reduced 79.75%
173,172 $611,000
Q2 2023

Aug 14, 2023
SELL
$3.45 - $5.97 $2.35 Million - $4.07 Million
-681,887 Reduced 79.75%
173,172 $611,000
Q1 2023

May 14, 2024
BUY
$4.19 - $16.83 $365,472 - $1.47 Million
87,225 Added 11.36%
855,059 $3.61 Million
Q1 2023

May 11, 2023
BUY
$4.19 - $16.83 $365,472 - $1.47 Million
87,225 Added 11.36%
855,059 $3.61 Million
Q4 2022

May 14, 2024
BUY
$8.74 - $16.45 $280,466 - $527,880
32,090 Added 4.36%
767,834 $12.6 Million
Q4 2022

Feb 13, 2023
BUY
$8.74 - $16.45 $280,466 - $527,880
32,090 Added 4.36%
767,834 $12.6 Million
Q3 2022

May 14, 2024
BUY
$10.67 - $22.41 $2.46 Million - $5.18 Million
230,988 Added 45.76%
735,744 $9.4 Million
Q3 2022

Nov 10, 2022
BUY
$10.67 - $22.41 $2.46 Million - $5.18 Million
230,988 Added 45.76%
735,744 $9.4 Million
Q2 2022

May 14, 2024
SELL
$3.94 - $11.77 $76,806 - $229,444
-19,494 Reduced 3.72%
504,756 $5.91 Million
Q2 2022

Aug 15, 2022
SELL
$3.94 - $11.77 $883,005 - $2.64 Million
-224,113 Reduced 30.75%
504,756 $5.91 Million
Q1 2022

May 16, 2022
BUY
$5.9 - $9.45 $1.44 Million - $2.3 Million
243,450 Added 50.15%
728,869 $4.44 Million
Q4 2021

Feb 14, 2022
BUY
$8.69 - $12.48 $74,855 - $107,502
8,614 Added 1.81%
485,419 $4.45 Million
Q3 2021

Nov 10, 2021
BUY
$8.43 - $16.81 $4.02 Million - $8.02 Million
476,805 New
476,805 $5.39 Million

Others Institutions Holding ALT

# of Institutions
189
Shares Held
42.3M
Call Options Held
1.05M
Put Options Held
582K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $330M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email